These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12638933)
21. Crit Line: instrument to aid fluid removal during hemodialysis. Sego S ANNA J; 1997 Jun; 24(3):347-8. PubMed ID: 9238907 [TBL] [Abstract][Full Text] [Related]
22. Risk factors for increased variability in dialysis delivery in haemodialysis patients. Brimble KS; Treleaven DJ; Onge JS; Carlisle EJ Nephrol Dial Transplant; 2003 Oct; 18(10):2112-7. PubMed ID: 13679488 [TBL] [Abstract][Full Text] [Related]
23. What are the potential solutions for the problems with current methods for quantifying hemodialysis?: the effective delivered dose. Depner T Semin Dial; 2008; 21(5):405-7. PubMed ID: 18945326 [No Abstract] [Full Text] [Related]
24. Monitoring intracellular, interstitial, and intravascular volume changes during fluid management procedures. Montgomery LD; Gerth WA; Montgomery RW; Lew SQ; Klein MM; Stewart JM; Medow MS; Velasquez MT Med Biol Eng Comput; 2013 Oct; 51(10):1167-75. PubMed ID: 23549923 [TBL] [Abstract][Full Text] [Related]
25. Physiological monitoring and control in hemodialysis: state of the art and outlook. Kraemer M Expert Rev Med Devices; 2006 Sep; 3(5):617-34. PubMed ID: 17064247 [TBL] [Abstract][Full Text] [Related]
26. What are the potential solutions for the problems with current methods for quantifying hemodialysis?: "difficult to remove" uremic toxins. Vanholder R; Eloot S; Van Biesen W Semin Dial; 2008; 21(5):407-9. PubMed ID: 18945327 [No Abstract] [Full Text] [Related]
27. A continuous and non-invasive arterial pressure monitoring system in dialysis patients. Mambelli E; Mancini E; Santoro A Nephron Clin Pract; 2007; 107(4):c170-6. PubMed ID: 17975324 [TBL] [Abstract][Full Text] [Related]
34. Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance. Uhlin F; Fridolin I; Magnusson M; Lindberg LG Nephrol Dial Transplant; 2006 Aug; 21(8):2225-31. PubMed ID: 16611681 [TBL] [Abstract][Full Text] [Related]
35. Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients. Chan D; Irish A; Croft KD; Dogra G Nephrol Dial Transplant; 2006 Jan; 21(1):234-5. PubMed ID: 16204285 [No Abstract] [Full Text] [Related]
36. Prediction of time-averaged concentration of haemoglobin in haemodialysis patients. Krisper P; Quehenberger F; Schneditz D; Holzer H; Polaschegg HD Nephrol Dial Transplant; 2003 Oct; 18(10):2082-7. PubMed ID: 13679484 [TBL] [Abstract][Full Text] [Related]
37. Adequacy of haemodialysis. Ford E EDTNA ERCA J; 2005; 31(1):4-8; quiz 9. PubMed ID: 16083018 [TBL] [Abstract][Full Text] [Related]
38. What are the potential solutions for the problems with current methods for quantifying hemodialysis?: calcium. Gotch F Semin Dial; 2008; 21(5):411-4. PubMed ID: 18945329 [No Abstract] [Full Text] [Related]
39. Predicting episodes of hypotension by continuous blood volume monitoring among critically ill patients in acute renal failure on intermittent hemodialysis. Tanguay TA; Jensen L; Johnston C Dynamics; 2007; 18(3):19-24. PubMed ID: 17879763 [TBL] [Abstract][Full Text] [Related]
40. Central venous oxygen saturation and thoracic admittance during dialysis: new approaches to hemodynamic monitoring. Cordtz J; Olde B; Solem K; Ladefoged SD Hemodial Int; 2008 Jul; 12(3):369-77. PubMed ID: 18638095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]